TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.66E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.55E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.89E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 5.93E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 974nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.23E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.57E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 3.97E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.03E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.18E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.15E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.38E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 118nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 435nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 508nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 128nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 146nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 185nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 152nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 57nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.82E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 165nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 3.93E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.18E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 499nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.31E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 394nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 8nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 14nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 5nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 7nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 1.08E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 420nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 827nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 2.00E+3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 746nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: >1.00E+4nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 378nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 370nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 593nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
US Patent
Affinity DataEC50: 570nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair